Have no insight on the cross, but I note that another 21K shares traded also. My own feeling is that this is a preface to news. I think we're going to see some changes, though I'm not expecting Q2 to be any good, with whatever the Tisma writedown will be. At the risk of being repetitive: the parasitical effect of Tisma will be gone, the backlog of orders is good, operating capital should be adequate, margins (and profitability) are up, there's a new CEO, a more diverse customer base with IPV's ventures into eastern Europe, and the Asian recovery looks sustainable and real, with repeating and new
customers. My guess is $0.15/shr in a year. A P/E of 20 should get us around $3; 10, around $1.50. If management serves us the news, good and bad, straight up, then I 'm guessing we'll all be happy, maybe even very happy, in about 2 years. |
